Generic Drug Maker Urges FDA To Create Incentives To Avert Shortages

To mitigate drug shortages, a not-for-profit generic drug company is proposing FDA, on its own and through collaboration with other government agencies, provide manufacturers with myriad incentives, including: reduced regulatory oversight, increased time between inspections, tax credits or federal grants, and fee waivers for certain generic companies. The company also suggests Congress fund a qualified manufacturing program at FDA along the lines of that run by the Biomedical Advanced Research and Development Authority. FDA also should create and maintain a...